Publication:
Clinical trial of flubendazole on hookworm, Trichuris trichiura and Ascaris lumbricoides infections

dc.contributor.authorD. Bunnagen_US
dc.contributor.authorT. Harinasutaen_US
dc.contributor.authorC. Viravanen_US
dc.contributor.authorV. Jarupakornen_US
dc.contributor.authorD. Chindanonden_US
dc.contributor.authorV. Desakornen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-04-30T08:36:53Z
dc.date.available2018-04-30T08:36:53Z
dc.date.issued1980-12-01en_US
dc.description.abstractFlubendazole, a parafluoro analogue of mebendazole, was given to 89 service men with hookworm, Trichuris trichiura and Ascaris lumbricoides infections. The drug was given either as 2 doses of 300 mg at 12 hour interval (regimen A) or as 2 doses of 300 mg at 24 hour interval (regimen B). At 4 weeks follow-up the mean percentage egg reduction for hookworm was 88% and 96% in regimen A and B respectively. There were too few cases of Trichuris and Ascaris infection to allow comparison of the two regimens, but flubendazole appeared to be as effective and the single day regimen more convenient than difetasone for trichuriasis and levamisole for ascariasis. Side effects were few, mild and transient.en_US
dc.identifier.citationSoutheast Asian Journal of Tropical Medicine and Public Health. Vol.11, No.3 (1980), 363-366en_US
dc.identifier.issn00383619en_US
dc.identifier.other2-s2.0-0019125859en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/11114
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0019125859&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleClinical trial of flubendazole on hookworm, Trichuris trichiura and Ascaris lumbricoides infectionsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0019125859&origin=inwarden_US

Files

Collections